ATE84221T1 - Arzneimittel mit methylcellulose. - Google Patents
Arzneimittel mit methylcellulose.Info
- Publication number
- ATE84221T1 ATE84221T1 AT89900745T AT89900745T ATE84221T1 AT E84221 T1 ATE84221 T1 AT E84221T1 AT 89900745 T AT89900745 T AT 89900745T AT 89900745 T AT89900745 T AT 89900745T AT E84221 T1 ATE84221 T1 AT E84221T1
- Authority
- AT
- Austria
- Prior art keywords
- containing methylcellulose
- medications containing
- immunomodulator
- medications
- methylcellulose
- Prior art date
Links
- 229920000609 methyl cellulose Polymers 0.000 title abstract 2
- 239000001923 methylcellulose Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 2
- 229940121354 immunomodulator Drugs 0.000 abstract 2
- 230000002584 immunomodulator Effects 0.000 abstract 2
- 102000015696 Interleukins Human genes 0.000 abstract 1
- 108010063738 Interleukins Proteins 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12839187A | 1987-12-03 | 1987-12-03 | |
| PCT/US1988/004267 WO1989005149A1 (en) | 1987-12-03 | 1988-11-30 | Methyl cellulose pharmaceutical composition |
| EP89900745A EP0390849B1 (de) | 1987-12-03 | 1988-11-30 | Arzneimittel mit methylcellulose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE84221T1 true ATE84221T1 (de) | 1993-01-15 |
Family
ID=22435139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89900745T ATE84221T1 (de) | 1987-12-03 | 1988-11-30 | Arzneimittel mit methylcellulose. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0390849B1 (de) |
| JP (1) | JPH03502574A (de) |
| AT (1) | ATE84221T1 (de) |
| CA (1) | CA1336397C (de) |
| DE (1) | DE3877365T2 (de) |
| WO (1) | WO1989005149A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4525589A (en) * | 1988-10-27 | 1990-05-14 | Regents Of The University Of Minnesota | Liposome immunoadjuvants containing il-2 |
| JPH0334920A (ja) * | 1989-04-21 | 1991-02-14 | Otsuka Pharmaceut Co Ltd | リポソームに結合及至組合わされた生物活性化合物及びそれを含有する医薬 |
| JPH0363298A (ja) * | 1989-07-31 | 1991-03-19 | Green Cross Corp:The | コロニー形成刺激因子・脂質複合体 |
| ATE171071T1 (de) * | 1991-12-31 | 1998-10-15 | Zymogenetics Inc | Verfahren und zusammensetzungen zur verminderung von blutverlust |
| US6387390B1 (en) | 1998-10-05 | 2002-05-14 | The Penn State Research Foundation | Compositions and methods for enhancing receptor-mediated cellular internalization |
| PT885002E (pt) * | 1996-03-04 | 2011-07-14 | Massachusetts Inst Technology | Materiais e métodos para aumento da internalização celular |
| CN1068227C (zh) * | 1997-05-29 | 2001-07-11 | 武汉迪普生物技术有限公司 | 干扰素脂质体凝胶剂 |
| JP2006111585A (ja) * | 2004-10-15 | 2006-04-27 | Mebiol Kk | 徐放性組成物およびその徐放方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5911563B2 (ja) * | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
| EP0090837A1 (de) * | 1981-10-08 | 1983-10-12 | BERG, Kurt Frimann | Verfahren und zusammensetzung zum behandeln von kranken die an interferon empfindlichen krankheiten leiden |
| DE3380726D1 (en) * | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
| US4680175A (en) * | 1984-02-07 | 1987-07-14 | Interferon Sciences, Inc. | Interferon administration vehicles |
| US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
| JPS6176414A (ja) * | 1984-09-21 | 1986-04-18 | Shionogi & Co Ltd | リポソーム製剤の製法 |
| DE3576117D1 (de) * | 1984-09-24 | 1990-04-05 | Michael Mezei | Mehrphasige pharmazeutische zusammensetzung. |
| US4762915A (en) * | 1985-01-18 | 1988-08-09 | Liposome Technology, Inc. | Protein-liposome conjugates |
| DE3682257D1 (de) * | 1985-11-22 | 1991-12-05 | Takeda Chemical Industries Ltd | Liposomzusammensetzung. |
| US4717717A (en) * | 1986-11-05 | 1988-01-05 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
-
1988
- 1988-11-30 DE DE8989900745T patent/DE3877365T2/de not_active Expired - Fee Related
- 1988-11-30 WO PCT/US1988/004267 patent/WO1989005149A1/en not_active Ceased
- 1988-11-30 JP JP1500608A patent/JPH03502574A/ja active Pending
- 1988-11-30 AT AT89900745T patent/ATE84221T1/de not_active IP Right Cessation
- 1988-11-30 EP EP89900745A patent/EP0390849B1/de not_active Expired - Lifetime
- 1988-12-02 CA CA000584807A patent/CA1336397C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3877365D1 (de) | 1993-02-18 |
| CA1336397C (en) | 1995-07-25 |
| JPH03502574A (ja) | 1991-06-13 |
| DE3877365T2 (de) | 1993-05-19 |
| EP0390849B1 (de) | 1993-01-07 |
| EP0390849A4 (en) | 1991-01-09 |
| EP0390849A1 (de) | 1990-10-10 |
| WO1989005149A1 (en) | 1989-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1231434B (it) | Composizione farmaceutica endovenosa e procedimento per la sua preparazione. | |
| IT8719064A0 (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive. | |
| DE68911473D1 (de) | Arzneimittelformulierungen. | |
| DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
| DE3578620D1 (de) | Arzneimittel zur aeusserlichen anwendung. | |
| NL190664C (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
| PT83872A (de) | Arzneimittel | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| DE3480599D1 (de) | 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. | |
| NL190580C (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
| NL192917B (nl) | Stabiele farmaceutische bereiding die granulocytkolonie-stimulerende factor bevat. | |
| DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| FI881061A7 (fi) | Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö. | |
| MX9203099A (es) | N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos. | |
| DE68909409D1 (de) | Heilmitteldosierung zur verabreichung an fische. | |
| NL8601838A (nl) | Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten. | |
| DE3882157D1 (de) | Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen. | |
| ATE84221T1 (de) | Arzneimittel mit methylcellulose. | |
| DE3576118D1 (de) | Pharmazeutische praeparate. | |
| FI925191A7 (fi) | Uudet oksatsolijohdannaiset, niiden valmistus ja niitä sisältävät farm aseuttiset valmisteet | |
| DE3874390D1 (de) | Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten. | |
| DE3866789D1 (de) | Pharmazeutische zusammensetzungen. | |
| NL193441B (nl) | Farmaceutisch preparaat voor veterinair gebruik. | |
| DE3871159D1 (de) | Pharmazeutische und tieraerztliche zusammensetzungen. | |
| NL191736C (nl) | Onverzadigde kamferderivaten en farmaceutische en kosmetische preparaten ervan. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |